Implementation of quality improvement coaching versus physician communication training for improving human papillomavirus vaccination in primary care: a randomized implementation trial
- PMID: 34244807
- PMCID: PMC8919808
- DOI: 10.1093/tbm/ibab071
Implementation of quality improvement coaching versus physician communication training for improving human papillomavirus vaccination in primary care: a randomized implementation trial
Abstract
Many US health departments (HDs) conduct in-person quality improvement (QI) coaching to help primary care clinics improve their HPV vaccine delivery systems and communication. Some HDs additionally conduct remote communication training to help vaccine prescribers recommend HPV vaccination more effectively. Our aim was to compare QI coaching and communication training on key implementation outcomes. In a cluster randomized trial, we offered 855 primary care clinics: 1) QI coaching; 2) communication training; or 3) both interventions combined. In each trial arm, we assessed adoption (proportion of clinics receiving the intervention), contacts per clinic (mean number of contacts needed for one clinic to adopt intervention), reach (median number of participants per clinic), and delivery cost (mean cost per clinic) from the HD perspective. More clinics adopted QI coaching than communication training or the combined intervention (63% vs 16% and 12%, both p < .05). QI coaching required fewer contacts per clinic than communication training or the combined intervention (mean = 4.7 vs 29.0 and 40.4, both p < .05). Communication training and the combined intervention reached more total staff per clinic than QI coaching (median= 5 and 5 vs 2, both p < .05), including more prescribers (2 and 2 vs 0, both p < .05). QI coaching cost $439 per adopting clinic on average, including follow up ($129/clinic), preparation ($73/clinic), and travel ($69/clinic). Communication training cost $1,287 per adopting clinic, with most cost incurred from recruitment ($653/clinic). QI coaching was lower cost and had higher adoption, but communication training achieved higher reach, including to influential vaccine prescribers.
Keywords: Cancer prevention; Human papillomavirus vaccine; IQIP; Implementation science; Physician communication; Quality improvement.
Plain language summary
Our cluster randomized trial compared two interventions that health departments commonly use to increase HPV vaccination coverage: quality improvement (QI) coaching and physician communication training. We found that QI coaching cost less and was more often adopted by primary care clinics, but communication training reached more staff members per clinic, including vaccine prescribers. Findings provide health departments with data needed to weigh the implementation strengths and challenges of QI coaching and physician communication training for increasing HPV vaccination coverage.
© Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Coaching and Communication Training for HPV Vaccination: A Cluster Randomized Trial.Pediatrics. 2022 Aug 1;150(2):e2021052351. doi: 10.1542/peds.2021-052351. Pediatrics. 2022. PMID: 35818840 Free PMC article. Clinical Trial.
-
Quality Improvement Coaching for Human Papillomavirus Vaccination Coverage: A Process Evaluation in 3 States, 2018-2019.Prev Chronic Dis. 2020 Oct 8;17:E120. doi: 10.5888/pcd17.190410. Prev Chronic Dis. 2020. PMID: 33034559 Free PMC article. Clinical Trial.
-
Coaching primary care clinics for HPV vaccination quality improvement: Comparing in-person and webinar implementation.Transl Behav Med. 2019 Jan 1;9(1):23-31. doi: 10.1093/tbm/iby008. Transl Behav Med. 2019. PMID: 29471460 Free PMC article. Clinical Trial.
-
Effectiveness of Quality Improvement Coaching on Process Outcomes in Health Care Settings: A Systematic Review.J Gen Intern Med. 2022 Mar;37(4):885-899. doi: 10.1007/s11606-021-07217-2. Epub 2022 Jan 3. J Gen Intern Med. 2022. PMID: 34981354 Free PMC article.
-
Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.Cochrane Database Syst Rev. 2019 Nov 22;2019(11):CD013479. doi: 10.1002/14651858.CD013479. Cochrane Database Syst Rev. 2019. PMID: 31755549 Free PMC article.
Cited by
-
Identifying and supporting vaccine champions in pediatric primary care: a qualitative interview study.Transl Behav Med. 2024 Nov 25;14(12):722-731. doi: 10.1093/tbm/ibae054. Transl Behav Med. 2024. PMID: 39402839 Free PMC article.
-
Partnering with healthcare systems to improve HPV vaccination:The perspective of immunization program managers.Hum Vaccin Immunother. 2021 Dec 2;17(12):5402-5406. doi: 10.1080/21645515.2021.1993041. Epub 2021 Oct 29. Hum Vaccin Immunother. 2021. PMID: 34715005 Free PMC article.
-
Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review.J Adolesc Health. 2024 May;74(5):868-877. doi: 10.1016/j.jadohealth.2023.11.016. Epub 2024 Jan 17. J Adolesc Health. 2024. PMID: 38231146 Free PMC article.
-
Mothers' perceptions and attitudes about HPV vaccination initiation among 9- and 10-year-olds.Hum Vaccin Immunother. 2023 Dec 15;19(3):2270842. doi: 10.1080/21645515.2023.2270842. Epub 2023 Nov 13. Hum Vaccin Immunother. 2023. PMID: 37955127 Free PMC article.
-
Feasibility of using an app-based coaching intervention to improve provider communication about HPV vaccination.Transl Behav Med. 2023 Aug 11;13(8):581-588. doi: 10.1093/tbm/ibad002. Transl Behav Med. 2023. PMID: 36999806 Free PMC article.
References
-
- Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep. 2016;65(49):1405–1408. - PubMed
-
- Elam-Evans LD, Yankey D, Singleton JA, et al. . National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years — United States, 2019. Morb Mortal Wkly Rep. 2020;69(33):1109–1116. Available at https://www.cdc.gov/mmwr/volumes/69/wr/mm6933a1.htm. Accessibility verified Apr 18, 2021. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical